LATS2 is mapped to chromosome 13q11-12 and was reported to be positively expressed in serous cystadenomas, with the expression levels gradually decreased in borderline cystadenomas and carcinomas of the ovary [24]. This evidence concerns the gene LATS2 and ovarian carcinoma.